![](/img/cover-not-exists.png)
PS-107-SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes
Marjot, Thomas, Green, Charlotte, Mcneil, Catriona, Cornfield, Thomas, Hazlehurst, Jonathan, Moolla, Ahmad, White, Sarah, Francis, Jane, Neubauer, Stefan, Cobbold, Jeremy, Hodson, Leanne, Tomlinson, JVolume:
70
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0618-8278(19)30119-7
Date:
April, 2019
File:
PDF, 56 KB
english, 2019